login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
INMUNE BIO INC (INMB) Stock News
USA
- NASDAQ:INMB -
US45782T1051
-
Common Stock
1.845
USD
+0.12 (+6.65%)
Last: 10/31/2025, 10:37:00 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
INMB Latest News, Press Relases and Analysis
All
Press Releases
17 hours ago - By: Chartmill
INMUNE BIO INC (NASDAQ:INMB) Reports Narrower-Than-Expected Q3 2025 Loss
19 hours ago - By: INmune Bio, Inc.
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update
a day ago - By: Benzinga
- Mentions:
IR
CDP
ENTG
BUD
...
Earnings Scheduled For October 30, 2025
8 days ago - By: INmune Bio, Inc.
INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025
8 days ago - By: INmune Bio, Inc.
INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025
17 days ago - By: INmune Bio, Inc.
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025
17 days ago - By: INmune Bio, Inc.
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025
a month ago - By: INmune Bio, Inc.
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal
a month ago - By: INmune Bio, Inc.
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal
2 months ago - By: INmune Bio, Inc.
INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult
2 months ago - By: INmune Bio, Inc.
INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult
2 months ago - By: Zacks Investment Research
INmune Bio (INMB) Loses 23.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
3 months ago - By: The Motley Fool
INmune Bio (INMB) Q2 Loss Widens 110%
3 months ago - By: INmune Bio, Inc.
INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Management Changes
3 months ago - By: Benzinga
- Mentions:
GSAT
PGY
ADV
REAL
...
Earnings Scheduled For August 7, 2025
3 months ago - By: INmune Bio, Inc.
INmune Bio’s CaRe PC Trial of INKmune™ in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints and Is Closed to Enrollment
3 months ago - By: INmune Bio, Inc.
INmune Bio’s CaRe PC Trial of INKmune™ in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints and Is Closed to Enrollment
3 months ago - By: INmune Bio, Inc.
INmune Bio Inc. to Report Second Quarter 2025 Financial Results and Provide Corporate Update on Thursday, August 7th
3 months ago - By: INmune Bio, Inc.
INmune Bio Inc. to Report Second Quarter 2025 Financial Results and Provide Corporate Update on Thursday, August 7th
3 months ago - By: INmune Bio, Inc.
INmune Bio to Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference
3 months ago - By: INmune Bio, Inc.
INmune Bio to Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference
3 months ago - By: INmune Bio, Inc.
INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference
3 months ago - By: INmune Bio, Inc.
INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference
4 months ago - By: Yahoo Finance
- Mentions:
NVDA
SPY
QQQ
META
...
Stock market today: S&P 500, Nasdaq jump to fresh records, capping stunning second-quarter comeback
4 months ago - By: INmune Bio, Inc.
INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4 months ago - By: INmune Bio, Inc.
INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4 months ago - By: Yahoo Finance
- Mentions:
QQQ
SPY
META
NVDA
...
Stock market today: Dow, S&P 500, Nasdaq rise as momentum builds for Trump trade deals, tax bill
Please enable JavaScript to continue using this application.